NCT07067203

Brief Summary

To investigate the correlation between the effect of quadriceps and hamstring strength on timed up and go scores in adults with tarns - tibial amputation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 5, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 16, 2025

Completed
Last Updated

July 16, 2025

Status Verified

July 1, 2025

Enrollment Period

1.6 years

First QC Date

July 5, 2025

Last Update Submit

July 5, 2025

Conditions

Keywords

Transtibial amputationtranstibial amputeeTimed up and goHamstring muscle strengthquadriceps muscle strengthTranstibial amputation - unilateral

Outcome Measures

Primary Outcomes (1)

  • Correlation between the effect of quadriceps and hamstring strength by using Lafayette hand held dynamometer on the average of timed up and go scores in adults with tarns - tibial amputation

    6 months

Study Arms (1)

Adults with Unilateral Transtibial Amputation

EXPERIMENTAL

Participants in this arm are adults aged 50 years or older with a unilateral transtibial amputation resulting from peripheral vascular disease or diabetic complications. All participants will have a K-level classification of 3 or 4 and a BMI within the normal range (18.5-29.9). Each participant will undergo two primary assessments: 1. Muscle Strength Measurement 2. Timed Up and Go (TUG) Test

Device: Lafayette hand held dynamometerDiagnostic Test: Timed up and Go test

Interventions

Muscle Strength Measurement: The strength of the quadriceps (knee extensors) and hamstrings (knee flexors) of the amputated limb will be measured using a handheld digital dynamometer (Nicholas MMT, Lafayette Instruments). Measurements will be taken with the prosthesis in place. Quadriceps strength will be assessed in a supine position with the knee at 30° flexion, while hamstring strength will be assessed in a prone position with the knee at 20° flexion. Each participant will perform three maximal effort trials after a practice attempt. The highest value will be scaled to body mass for analysis.

Adults with Unilateral Transtibial Amputation
Timed up and Go testDIAGNOSTIC_TEST

Timed Up and Go (TUG) Test: Participants will complete a standardized 3-meter TUG assessment to evaluate functional mobility. The test will be broken down into five components: standing, walking, turning, returning, and sitting. After one practice run, two timed trials will be conducted, and the average of both will be used for analysis. All procedures will be conducted by trained physical therapists following a standardized protocol.

Adults with Unilateral Transtibial Amputation

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All participants age 50 years or older, with the reason for amputation either peripheral vascular disease or diabetic complications (Nadollek \& Brauer, 2002).
  • Unilateral transtibial amputation only (Wood, 2022).
  • K-level (2 to 4) (Gailey et al., 2002).
  • Normal Body mass index ranged from 18.5 to 30.0 (Nuttall, 2015).

You may not qualify if:

  • Residual limb revision in the past six months (Wood, 2022).
  • Open wounds or sores on the residual limb limiting the ability to don/doff prosthesis (Wood, 2022).
  • Uncontrolled comorbidities such as cardiovascular disease, active cancer treatment, and uncontrolled Diabetes Mellitus (Wood, 2022).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physical Therapy College Cairo University

Giza, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 5, 2025

First Posted

July 16, 2025

Study Start

September 1, 2023

Primary Completion

April 25, 2025

Study Completion

May 27, 2025

Last Updated

July 16, 2025

Record last verified: 2025-07

Locations